MoneyWorks4Me

The total revenue surged to Rs. 3367.49 millions, up 499.14% for the December 2024 quarter as against Rs. 562.05 millions during the year-ago period.The Net Loss for the quarter ended December 2024 is Rs. -730.23 millions as compared to Net Loss of Rs. -1606.24 millions of corresponding quarter ended December 2023 Operating profit Margin for the quarter ended December 2024 improved to 1053.93% as compared to -92.32% of corresponding quarter ended December 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202412 202312 % Var
Sales 3367.49 562.05 499.14 3367.49 562.05 499.14 3367.49 562.05 499.14
Other Income 50.14 11.07 352.94 50.14 11.07 352.94 50.14 11.07 352.94
PBIDT 1053.93 -92.32 -1241.61 1053.93 -92.32 -1241.61 1053.93 -92.32 -1241.61
Interest 439.17 260.06 68.87 439.17 260.06 68.87 439.17 260.06 68.87
PBDT -390.47 -1410.99 -72.33 -390.47 -1410.99 -72.33 -390.47 -1410.99 -72.33
Depreciation 339.76 195.25 74.01 339.76 195.25 74.01 339.76 195.25 74.01
PBT -730.23 -1606.24 -54.54 -730.23 -1606.24 -54.54 -730.23 -1606.24 -54.54
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -730.23 -1606.24 -54.54 -730.23 -1606.24 -54.54 -730.23 -1606.24 -54.54
Equity 114.43 40.10 185.36 114.43 40.10 185.36 114.43 40.10 185.36
PBIDTM(%) 31.30 -16.43 -290.54 31.30 -16.43 -290.54 31.30 -16.43 -290.54
Peers
Company Name CMP
Sun Pharma. Inds. 1864.00
Dr. Reddys Labs. 1140.80
Cipla 1380.00
Lupin 2075.00
Zydus Lifesciences 1118.00
View more..